1. The Chicago City Council passed an ordinance that requires all pharmaceutical sales reps to undergo ethics and marketing training. The license costs $750 and must be renewed each year. (STAT)

2. Ron Cohen, president and CEO of Acorda Therapeutics and chair of the industry group BIO, said he hopes that Robert Califf will remain in his post as FDA commissioner during the Trump administration. “Rob Califf is almost universally regarded as a strong leader, and he could do a lot of good if he were left in his position,” he said. (RAPS)

3. The number of high-prescribing doctors in the government’s Medicare prescription drug program has risen dramatically. Twenty-one doctors prescribed $5 million worth of prescriptions in 2011, compared to 514 last year. (NPR)

4. Sandoz, the generic arm of Novartis, published a study in the British Journal of Dermatology demonstrating that its biosimilar version of Enbrel, when switched with its reference product, showed no impact on safety or efficacy in patients.

5. A survey conducted by Chattem, Sanofi’s U.S. consumer healthcare division, found that nearly 90% of the 16,000 adult men respondents are more confident in their ability to manage their health than they are about making career decisions.